JSH-23
CAS No. 749886-87-1
JSH-23 ( NF-κB Activation Inhibitor II )
产品货号. M15858 CAS No. 749886-87-1
JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥515 | 有现货 |
|
| 5MG | ¥853 | 有现货 |
|
| 10MG | ¥1159 | 有现货 |
|
| 25MG | ¥1841 | 有现货 |
|
| 50MG | ¥2762 | 有现货 |
|
| 100MG | ¥3978 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥917 | 有现货 |
|
生物学信息
-
产品名称JSH-23
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。
-
产品描述JSH-23 is an inhibitor of NF-κB transcriptional activity with IC50 of 7.1 μM.(In Vitro):JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.(In Vivo):JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats.
-
体外实验JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.Cell Cytotoxicity Assay Cell Line:Macrophages RAW 264.7 Concentration:1, 3, 10, 30, 100, 300 μM Incubation Time:24 hours Result:Did not show significant cytotoxic effects at <100 μM.Western Blot Analysis Cell Line:Macrophages RAW 264.7 with LPS-stimulated Concentration:30 μM Incubation Time:1 hour Result:Decreased nuclear content of NF-κB p65 in a dose-dependent manner, corresponding to 49±4% inhibition at 3 μM, 75±7% at 10 μM and 95±8% at 30 μM.
-
体内实验JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats. Animal Model:Male Sprague Dawley diabetic rats (250-270 g)Dosage:1 mg/kg, 3 mg/kg Administration:Orally administered; daily; for 2 weeks Result:Produced significant improvement in motor nerve conduction velocity (MNCV).
-
同义词NF-κB Activation Inhibitor II
-
通路Apoptosis
-
靶点NF-κB
-
受体NF-κB
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number749886-87-1
-
分子量240.34
-
分子式C16H20N2
-
纯度>98% (HPLC)
-
溶解度Ethanol: 20 mg/mL (83.21 mM); DMSO: 48 mg/mL (199.71 mM)
-
SMILESNC1=CC(C)=CC=C1NCCCC2=CC=CC=C2
-
化学全称4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kasparkova J, et al. FEBS J. 2014, doi: 10.1111/febs.1271
产品手册
关联产品
-
Iguratimod
一种新型缓解疾病抗风湿化合物,可抑制 NF-κB (NF-κB) p65 亚基 (RelA) 磷酸化和核转位,而不影响 IKBα 降解。
-
AP-1/NF-κB activatio...
AP-1/NF-κB activation inhibitor 1 是一种有效的 AP-1 和NF-κB 介导的转录激活抑制剂(IC50=1 μM),不阻断 β-actin 启动子驱动的基础转录。AP-1/NF-κB activation inhibitor 1 对受刺激细胞产生IL-2和IL-8水平有相似的抑制作用。
-
Amgen16
Amgen 16 (Amgen16) 是一种高效的 NF-κB 诱导激酶 (NIK) 抑制剂,Ki 为 2 nM。
021-51111890
购物车()
sales@molnova.cn

